We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Upland Software
UPLD
$14.7M
| $55.8K | ﹤0.01% |
+3,899
| New | +$74.3K |
|
2802
IZEA Worldwide
IZEA
$60.6M
| $55.5K | ﹤0.01% |
+12,682
| New | +$61.7K |
|
|
GRO
2803
Brazil Potash Corp
GRO
$124M
| $55.4K | ﹤0.01% |
29,318
-5,074
| -15% | -$11.5K |
|
|
TVRD
2804
Tvardi Therapeutics
TVRD
$22.5M
| $55.2K | ﹤0.01% |
+12,838
| New | +$115K |
|
2805
SOPHiA GENETICS
SOPH
$464M
| $54.9K | ﹤0.01% |
+11,760
| New | +$53.3K |
|
|
LAC
2806
Lithium Americas
LAC
$958M
| $54.8K | ﹤0.01% |
12,572
-93,089
| -88% | -$537K |
|
2807
Neuraxis
NRXS
$75.7M
| $54.8K | ﹤0.01% |
12,068
-13,328
| -52% | -$39.8K |
|
2808
Entravision Communication
EVC
$1.02B
| $54.3K | ﹤0.01% |
18,526
+8,120
| +78% | +$21.1K |
|
|
VIP
2809
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37M
| $54.3K | ﹤0.01% |
36,673
+10,161
| +38% | +$17.6K |
|
2810
SenesTech
SNES
$6.89M
| $54.1K | ﹤0.01% |
+25,273
| New | +$78.9K |
|
2811
GrowGeneration
GRWG
$86.5M
| $54K | ﹤0.01% |
36,011
-30,640
| -46% | -$50.3K |
|
2812
Community Health Systems
CYH
$388M
| $54K | ﹤0.01% |
17,309
-45,880
| -73% | -$154K |
|
|
IONR
2813
Ioneer
IONR
$253M
| $54K | ﹤0.01% |
+11,241
| New | +$55.1K |
|
2814
Century Casinos
CNTY
$32.4M
| $53K | ﹤0.01% |
39,859
+23,909
| +150% | +$42.7K |
|
2815
Fortress Biotech
FBIO
$112M
| $52.8K | ﹤0.01% |
+14,433
| New | +$41.1K |
|
2816
Telomir Pharmaceuticals
TELO
$83.2M
| $52.8K | ﹤0.01% |
+39,712
| New | +$57.3K |
|
2817
Aemetis
AMTX
$101M
| $52.4K | ﹤0.01% |
+37,718
| New | +$75.9K |
|
|
CGTL
2818
Creative Global Technology Holdings
CGTL
$7.72M
| $52.4K | ﹤0.01% |
+2,937
| New | +$31.9K |
|
2819
Alta Equipment Group
ALTG
$196M
| $52.4K | ﹤0.01% |
11,382
-10,303
| -48% | -$56.6K |
|
|
NOTE
2820
DELISTED
FiscalNote
NOTE
| $52.2K | ﹤0.01% |
35,516
+20,166
| +131% | +$61.3K |
|
|
GCL
2821
GCL Global Holdings
GCL
$61.1M
| $52.1K | ﹤0.01% |
48,682
+38,127
| +361% | +$61.5K |
|
2822
XBiotech
XBIT
$68.9M
| $51.9K | ﹤0.01% |
21,703
+6,647
| +44% | +$16.4K |
|
2823
Rockwell Medical
RMTI
$27.2M
| $51.8K | ﹤0.01% |
6,210
+4,603
| +286% | +$46.4K |
|
2824
Acco Brands
ACCO
$395M
| $51.6K | ﹤0.01% |
13,840
-8,443
| -38% | -$31.3K |
|
|
OKUR
2825
OnKure Therapeutics
OKUR
$159M
| $51.6K | ﹤0.01% |
+17,801
| New | +$53.3K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.